Abstract
Calmodulin-based genetically encoded fluorescent calcium indicators (GCaMP-s) are powerful tools of imaging calcium dynamics from cells to freely moving animals. High affinity indicators with slow kinetics however distort the temporal profile of calcium transients. Here we report the development of reduced affinity ultrafast variants of GCaMP6s and GCaMP6f. We hypothesized that GCaMP-s have a common kinetic mechanism with a rate-limiting process in the interaction of the RS20 peptide and calcium-calmodulin. Therefore we targeted specific residues in the binding interface by rational design generating improved indicators with GCaMP6fu displaying fluorescence rise and decay times (t1/2) of 1 and 3 ms (37 °C) in vitro, 9 and 22-fold faster than GCaMP6f respectively. In HEK293T cells, GCaMP6fu revealed a 4-fold faster decay of ATP-evoked intracellular calcium transients than GCaMP6f. Stimulation of hippocampal CA1 pyramidal neurons with five action potentials fired at 100 Hz resulted in a single dendritic calcium transient with a 2-fold faster rise and 7-fold faster decay time (t1/2 of 40 ms) than GCaMP6f, indicating that tracking high frequency action potentials may be limited by calcium dynamics. We propose that the design strategy used for generating GCaMP6fu is applicable for the acceleration of the response kinetics of GCaMP-type calcium indicators.
Genetically encoded Ca2+ indicators (GECI) facilitated monitoring Ca2+ dynamics in intact and even freely moving animals. A limiting factor in the application of GECI has been their high Ca2+ affinity and slow response kinetics1. In GCaMP-type GECI2,3,4,5,6,7,8,9,10,11 Ca2+ binding to calmodulin (CaM) induces the formation of a complex with a target peptide which in turn restores the fluorescence of circularly permutated (cp) EGFP12. The Ca2+-induced binding of CaM to a target peptide allows the detection of Ca2+ signals also by GCaMP-related G-GECO-s13, GEM-GECO-s13 and sub-cellularly targeted CEPIA14 and GCaMPer15. Further broadening of the approaches for non-invasive mapping of neuronal circuits is represented by the development of red fluorescent probes for optogenetic stimulation and of photoactivatable derivatives13,16,17,18. The most commonly used target peptide is RS20, a smooth muscle myosin light chain kinase-derived peptide and, in the case of RCaMP2, a CaMKKα-derived peptide16. GCaMP-s reported to have the greatest brightness and Ca2+ induced fluorescence enhancement to date are variants of a GCaMP6 generation termed GCaMP6 slow, GCaMP6 medium and GCaMP6 fast (GCaMP6s, GCaMP6m and GCaMP6f)19 as well as GCaMP720 and GCaMP821. Even though indicators such as GCaMP7 show sufficiently high level of brightness to detect single action potentials (AP-s)22, their slow kinetic properties due to the Ca2+ - CaM - RS20 peptide interaction limit achieving temporal fidelity. Typically, Ca2+ - CaM - RS20 interactions have a high affinity (half-maximal brightness concentration, Kd values of 100–300 nM) as for GCaMP6s and GCaMP6f19. Correspondingly, the Ca2+ dissociation rates and thus the signal decay rates are slow, 1–5 s−1 at 20 °C, comparable to that of GCaMP310. By rational design, mutations at the Ca2+ - CaM - RS20 binding interface have produced GCaMP3- and GCaMP6f-derived probes with improved decay kinetics23,24. The probe with the fastest signal rise (t1/2 of 1 ms) and decay (t1/2 of 3 ms) kinetics (37 °C) so far is GCaMP3fast25. The mutation strategy that gave rise to GCaMP3fast can serve as a template for generating fast-response CaM-based GECI.
Design template for ultrafast GCaMP-s
We developed a strategy to generate fast-response GCaMP-type GECI by introducing specific mutations at the Ca2+ - CaM - RS20 peptide interface to weaken their interactions. In CaM, Ca2+ binding sites are disabled by asingle-point mutation of the first Asp to Ala in each EF-hand Ca2+ binding loop. The EF-3 mutation denotes a mutant with the third Ca2+ site inactivated, EF-4 with the fourth site. A mutation termed RS-1 which substitutes the Trp residue in position 43 for Tyr in the RS20 peptide sequence, further weakens the Ca2+- CaM - peptide interaction26 (Fig. 1a). Four trends are commonly observed when the mutational strategy is applied to GCaMP3, G-GECO and GEM-GECO. First, mutation of EF-1 and/or EF-2 causes loss of fluorescence signal24,25. Second, the EF-4 and combined RS-1 EF-4 mutations consistently retain or have increased brightness and dynamic range together with faster kinetics than the parent proteins25. Third, GCaMP3, G-GECO and GEM-GECO probes with the EF-3:4 double mutation alone or in combination with RS-1 have low affinity (mM Kd) and fast kinetics. Although the lower brightness and dynamic range of the EF-3:4 double mutants requires improvement, kinetically they are thus promising for development of extracellular or intra-organelle Ca2+ probes. Finally, the combination of mutations EF-3 and RS-1 results in the fastest response kinetics and has given the to-date most kinetically improved probe mGCaMP3 RS-1 EF-3 (GCaMP3fast) which has Ca2+ rise and decay times of 1–3 ms25.
We applied the strategy used to produce GCaMP3fast to the popular bright probes GCaMP6s and GCaMP6f. Here we test the hypothesis that the EF-3, EF-4 and RS-1 mutations and their combinations result in significantly faster kinetics when applied to CaM-based GECI. We have generated twelve mutant probes, six each for GCaMP6s and for GCaMP6f19. Biophysical characterisation revealed that, as predicted, the fastest responding probe was given by the RS-1 (W43Y) EF-3 (D395A) mutation combination. mGCaMP6f RS-1 EF-3, termed GCaMP6f-ultrafast (GCaMP6fu) has 1 ms rise and 3 ms decay half times in vitro (37 °C). The temperature dependence of the fluorescence response kinetics of the probes is analyzed to enable predictions for physiological applications and for better understanding of the molecular mechanisms of GCaMP probes. A kinetic model is proposed for the processes through which fluorescence develops in CaM-based GCaMP-s. Faster response kinetics by GCaMP6fu compared to GCaMP6f are demonstrated in ATP-stimulated cells and in neurons stimulated by high frequency action potentials.
Results
Biophysical properties of GCaMP6f u and selected mGCaMP6s and mGCaMP6f
First the effects of the mutations on the fluorescence brightness and dynamic range of the probes were determined. Quantum yield (Φ+Ca2+) measurements revealed that the EF-4 and RS-1 EF-4 mutations had little effect on the Φ+Ca2+ of GCaMP6s and GCaMP6f. Using the reported value of 0.59 at 20 °C for GCaMP6f19, we obtained a Φ+Ca2+ value of 0.58 for GCaMP6s and 0.46 for GCaMP6fu. With measured molar extinction coefficients εo(497 nm) of 50294 ± 259 M−1cm−1 for Ca2+-saturated GCaMP6f and 1564 ± 1140 M−1cm−1 for Ca2+-saturated GCaMP6fu, brightness values of 29673 and 7197 M−1cm−1 were obtained for GCaMP6f and GCaMP6fu, respectively. Similarly, Ca2+-induced fluorescence increases (Fr(+Ca2+)), expressed relative to apo-GCaMP6s (Fr(−Ca2+) of 1)) of 27 for GCaMP6s and 15 for GCaMP6f19, were little affected by the EF-4 and RS-1 EF-4 mutations. Fr(+Ca2+)/Fr(−Ca2+) of GCaMP6s RS-1 EF-3 and GCaMP6fu were reduced to 18 and 5, respectively (Table 1 and Supplementary Table S1). Even though the brightness for GCaMP6fu is 4-fold reduced compared to GCaMP6f, the value remains comparable to GCaMP3 probe which has been widely used for in vivo experiments including calcium measurements in free-moving animals (Fmax/Fmin for GCaMP6f = 14.6, GCaMP6fu = 5.1 and GCaMP3 = 6.3)25. pKa values of ~7 were measured for GCaMP6s and GCaMP6f together with their mutants at 20 °C in agreement with previously reported values (Supplementary Fig. S1)19.
Table 1. Comparison of the biophysical characteristics of GCaMP6f and GCaMP6f u .
Fr |
Fr(+Ca2+)/Fr(−Ca2+) | Kd (μM) | n | kon (s−1) | t1/2(on) (ms) | koff (s−1) | t1/2(off) (ms) | |||
---|---|---|---|---|---|---|---|---|---|---|
−Ca2+ | +Ca2+ | |||||||||
GCaMP6f | 20 °C | 0.9 ± 0.1 | 14.4 ± 3.4 | 14.6 ± 2.4 | 0.22 ± 0.01 | 2.8 ± 0.1 | 315 ± 9 (0.3)a | 2.2 ± 0.1 (0.3)a | 2.4 ± 0.1 | 288 ± 12 |
38 ± 1 (0.7)a | 18 ± 0.5 (0.7)a | |||||||||
37 °C | 1.0 ± 0.1 | 13.8 ± 0.1 | 13.2 ± 0.1 | 0.09 ± 0.01 | 3.4 ± 0.1 | 66 ± 1 | 10 ± 0.2 | 11 ± 1 | 63 ± 6 | |
GCaMP6fu(mGCaMP6f RS-1 EF-3) | 20 °C | 1.0 ± 0.1 | 5.1 ± 0.4 | 5.1 ± 0.1 | 0.89 ± 0.01 | 3.0 ± 0.1 | 142 ± 4 | 4.9 ± 0.1 | 89 ± 1 | 7.8 ± 0.1 |
37 °C | 0.9 ± 0.1 | 3.8 ± 0.2 | 4.1 ± 0.2 | 0.34 ± 0.01 | 3.0 ± 0.3 | 546 ± 44b | 1.3 ± 0.02b | 245 ± 10 | 2.8 ± 0.1 |
aBiphasic association kinetic records were fitted with two exponentials. The rise t1/2 of each phase is given with the relative amplitudes in parentheses.
bMeasurements were made in the range of 15 to 30 °C. The rate was too fast to measure at 37 °C and was extrapolated from the Arrhenius plot assuming the gradient remaining unchanged (Fig. 2e).
Equilibrium Ca2+ binding
The mutations were expected and found to increase the equilibrium half-maximal brightness concentration (Kd) values of the probes. Cooperativity for Ca2+ remained high, characterised by Hill coefficient (n) values of ~2–3. Comparison of affinities at 20 °C and 37 °C revealed that Kd-s decreased with increasing temperature: for GCaMP6f, from 220 nM to 88 nM, respectively (Fig. 1b), for GCaMP6fu from 890 nM to 340 nM (Fig. 1c, Table 1) and for the lower affinity mGCaMP6f EF-4, from 1.6 μM to 840 nM (Supplementary Fig. S2,S3, Supplementary Table S1).
mGCaMP6f RS-1 EF-4 and the EF-3:4 double mutants of both GCaMP6s and GCaMP6f revealed two independent sets of Ca2+ binding sites: high affinity (1–6 μM Kd) with n of 2 and low affinity (0.2–6 mM Kd) with n of 1. The high affinity Kd decreased with temperature while the low affinity Kd increased. Moreover, while 80% of the total fluorescence enhancement of mGCaMP6f RS-1 EF-4 occurred with high affinity at 20 °C, at 37 °C, a temperature closer to those in physiological applications, the lower affinity component dominated representing 70% of the signal (Supplementary Fig. S3 and Supplementary Table S1, S2). The apparent binding to three sites shown by the EF-3:4 double mutants may be explained by residual Ca2+ binding to a mutated C-lobe site.
Ca2+ decay kinetics
Typically, faster fluorescence decay rates were expected for the EF-3, EF-4 and RS-1 mutants of GCaMP6s and GCaMP6f compared to their parent proteins at all temperatures (Supplementary Fig. S4, S5). t1/2 at 20 °C of 769 ms for GCaMP6s was reduced to 216 ms by the RS-1 EF-3 mutation. The same mutation in GCaMP6f, giving GCaMP6fu brought down the decay t1/2 from 288 ms to 7.8 ms (Fig. 1e, Table 1 and Supplementary Table S1).
In spite of decreasing Kd values by increased temperatures, the fluorescence decay rates were 2–5-fold increased at 37 °C compared to 20 °C (Supplementary Fig. S4,S5 and Supplementary Tables S1,S2). At 37 °C, the fastest mGCaMP6s probe, mGCaMP6s RS-1 EF-3, had a 6.5-fold increased Ca2+ decay rate compared to GCaMP6s with the t1/2 of 346 ms reduced to 53 ms. t1/2 at 20 °C of 288 ms of GCaMP6f was reduced to 63 ms at 37 °C (Fig. 1d). The most significant improvements in the Ca2+ dissociation kinetics were however achieved by the RS-1 EF-3 mutations of GCaMP6f yielding the probe GCaMP6fu with a 23-fold faster fluorescence decay t1/2 of 3 ms at 37 °C (Fig. 1f and Supplementary Fig. S6).
Ca2+ rise kinetics
Stopped-flow fluorimetry revealed biphasic Ca2+ association kinetics for both GCaMP6s and GCaMP6f and for most of their mutants at 20 °C. The exceptions were mGCaMP6s RS-1 EF-4, GCaMP6fu and mGCaMP6f EF-3:4 which had a monophasic fluorescence rise (Fig. 2 and Supplementary Fig. S7, S8). [Ca2+] dependency of the rise rates revealed a switch-like response with limiting rates for each phase (kon(lim)). The fastest rate was measured for GCaMP6fu which, responding in an all-or-none manner to [Ca2+] rise, had a single rise t1/2 of 5 ms at 20 °C (Fig. 2c).
Examination of the temperature dependence of the Ca2+ rise kinetics reveals the kinetic advantage of GCaMP6fu over GCaMP6f at 37 °C (Fig. 2 and Supplementary Fig. S9). The fast phase of Ca2+ induced fluorescence enhancement of GCaMP6f has a limiting rate of 315 s−1 (rise t1/2 2 ms) and at 20 °C represents 30% of the fluorescence enhancement. The rate of the fast phase is essentially independent of temperature in the range of 20 °C to 30 °C, however with a diminishing amplitude of only 10% at 30 °C and no longer measurable at 37 °C. The rate of the slow phase is ~2-fold increased from 38 s−1 to 66 s−1 over the temperature range of 20 °C to 37 °C, representing the only measurable rate for GCaMP6f at 37 °C. The apparent Ca2+ response of GCaMP6f is thus slower at 37 °C than 20 °C. In contrast, the single observed limiting rate for mGCaMP6f RS-1 EF-3 (GCaMP6fu) is ~4-fold increased, to an extrapolated 546 s−1 at 37 °C, from 142 s−1 at 20 °C giving a fluorescence rise time of 1 ms.
Complexities are revealed in the temperature dependencies of the Ca2+ rise kinetics of GCaMP6s and mGCaMP-s as well (Fig. 2, Supplementary Fig. S10). In the case of GCaMP6s, the relative amplitudes of the fast and slow phases change with temperature such that at physiological ionic strength and 20 °C the amplitudes are about even, however at 37 °C the slow phase (rise t1/2 12 ms) represents 90% of the signal (Supplementary Table S1). Arrhenius plots for mGCaMP6f RS-1 EF-4 reveal opposite temperature dependencies for the rate of the fast and slow phases of its biphasic Ca2+ association kinetics: while the rate of the fast phase is 2-fold increased, the rate of the slow decay component is 2.5-fold lowered when the temperature increases from 20 °C to 37 °C (Supplementary Fig. S11d and Supplementary Table S1).
Kinetic mechanism of GCaMP-type GECI
As the fluorescence increase evoked by Ca2+ is based on the effect of the Ca2+ - CaM - RS20 peptide interaction on the structure of the cpEGFP domain, a common reaction mechanism previously described for GCaMP3 and its fast variants is expected to operate for GCaMP-s in general25. In essence, partially and fully Ca2+- and peptide-bound intermediates create two main fluorescent states in the rise phase of Ca2+-induced fluorescence. In the decay phase evoked by Ca2+ sequestration, Ca2+ leaving initiates dissociation of the complex and the return to the resting low-fluorescence state (Fig. 3). Fitted curves to the stopped-flow kinetic Ca2+ association and dissociation records obtained at 20 °C, 30 °C and 37 °C for GCaMP6f and GCaMP6fu were generated using a set of fitted parameters consistent with the data (Fig. 2 and Supplementary Table S3).
Fluorescence dynamic range measurements of GCaMP6f and GCaMP6s variants in HEK293T cells
Fluorescence dynamic range values for mGCaMP6s and mGCaMP6f probes were measured in ionomycin stimulated HEK293T cells. GCaMP6s continued to have the greatest fluorescence enhancement with ΔF/F0 of 18. In contrast to ΔF/F0 for GCaMP6f of 11, GCaMP6fu had ΔF/F0 of ~ 7. Fluorescence dynamic range values obtained in cellular environment were generally reduced compared to those in solution, except for GCaMP6fu, and for mGCaMP6s EF-3:4 (Supplementary Fig. S12).
Imaging intracellular Ca2+ release dynamics in ATP-stimulated HEK293T cells by GCaMP6f, GCaMP6f u and mGCaMP6f RS-1 EF-4
Intracellular Ca2+ dynamics were monitored in ATP-stimulated HEK293T cells and the time courses of the Ca2+ transient evoked by GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 were compared. GCaMP6f fluorescence increased (ΔF/F0 of 3.1 ± 0.35) with a decay time t1/2 of 9.4 ± 0.2 s. In comparison, GCaMP6fu and mGCaMP6f RS-1 EF-4 both showed lower dynamic ranges (ΔF/F0 of 0.2 ± 0.02) and significantly reduced, 2.3 ± 0.04 s decay time. Faster probes GCaMP6fu and mGCaMP6f RS-1 EF-4 thus revealed that ATP-induced intracellular Ca2+ release dynamics were more rapid than reported by GCaMP6f (Fig. 4a).
Response of GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 to high frequency stimulation in neurons
GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 expressed in hippocampal CA1 pyramidal neurons in organotypic hippocampal slices were distributed homogenously. Baseline fluorescence of all three indicators was bright enough to readily identify expressing cells. Fluorescence dynamic ranges (ΔF/F0) were 5.9 ± 0.3, 0.8 ± 0.05 and 0.5 ± 0.04 for GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4, respectively, consistent with small [Ca2+] changes. Notably, GCaMP6f achieved a significantly higher ΔF/F0 value throughout the 10–100 Hz range tested compared to GCaMP6fu and mGCaMP6f RS-1 EF-4. Due to its low Kd for Ca2+, only GCaMP6f was able to detect the low post-synaptic [Ca2+] elevation evoked by 5 AP-s fired at 10 Hz. For the same reason, however, the kinetics of GCaMP6f response were the most prolonged. With their higher Kd values GCaMP6fu and mGCaMP6f RS-1 EF-4 did not show a response to stimulation up to 20–40 Hz frequency and the dynamic range remained low. The kinetic advantage of GCaMP6fu and mGCaMP6f RS-1 EF-4 became evident at stimulation at 40 Hz or greater (Fig. 4b,c and Supplementary Fig. S13) and was particularly clear at 100 Hz: compared to GCaMP6f, GCaMP6fu and mGCaMP6f RS-1 EF-4 responded with much faster rise and decay kinetics to the [Ca2+] elevation evoked by trains of 5 AP-s. For GCaMP6f, following 50 ms stimulation at 100 Hz, the Ca2+ signal is still rising for another ~ 75 ms and then decays over ~ 400 ms19 (Fig. 4b). mGCaMP6f RS-1 EF-4 has improved kinetics with the signal decaying only~20 ms after stimulation, with a t1/2 of 91 ± 17 ms (Supplementary Fig. S13). The fastest response is achieved by GCaMP6fu: the Ca2+ signal decay commences as soon as the stimulation is finished, and returns to baseline with a t1/2 of 40 ± 2 ms, thus reducing the refractory period of detection following a stimulation event from hundreds to tens of milliseconds (Fig. 4c).
Discussion
The aim of this work was to reveal generally applicable modifications for the generation of fast-response GCaMP-like GECI for more accurate time resolution of Ca2+ signalling events. The combination of RS-1 and EF-3 mutations gave mGCaMP3 RS-1 EF-3 (GCaMP3fast) which has a 1 ms rise and 3 ms decay t1/2 at 37 °C25. The application of GCaMP3fast in cardiac myocytes revealed faster Ca2+ transients then previously indicated by slow indicators25. Here we report that the same design template when used on GCaMP6f results in similarly fast on and off response kinetics and propose that the RS-1 EF-3 mutation combination is applicable for the generation of ultrafast GCaMP-s.
While the RS-1 (W43Y) EF-3 (D395A) mutation pair has equal effects on the kinetics of GCaMP3 and GCaMP6f, they differently affect the brightness and dynamic range of their parent variants: GCaMP3fast retains the brightness of GCaMP3, whereas GCaMP6fu is 4-fold decreased compared to GCaMP6f. Even though GCaMP6m is significantly brighter than GCaMP3, the alignment of their crystal structures (PDB codes 3SG3 and 3WLD) reveals only subtle differences in the position of helix I and the linker region to cpEGFP3,27. The brightness and fluorescence dynamic range of GCaMP6f are higher than of GCaMP3 because of the introduction of the ‘stabilising’ mutations in the linker region connecting the CaM N-terminus to cpEGFP (T302L, R303P) and in helices I, IV and V of CaM (A317E, D380Y/T381R/S383T, R392G, respectively) (Fig. 5a,b). In particular, the T302L, R303P, D380Y hydrophobic mutations at the interface between CaM and cpEGFP result in similarly increased brightness and dynamic range in GCaMP5G and GCaMP6f3,19. The gain of brightness is likely due to a structural rearrangement involving these crucial hydrophobic residues not present in GCaMP3 as described below. These mutations decrease the flexibility of the cpEGFP - CaM helix I linker, through interaction between helix IV-V and cpEGFP - CaM helix I linkers. Specifically, the T302L, R303P, D380Y mutations play the most significant roles in ordering/positioning cpEGFP - CaM helix I linker, as GCaMP5G is almost as bright as GCaMP6f. The R303P mutation decreases flexibility and increases order in the cpEGFP - CaM helix I linker, thus positioning the mutated L302 and Y380 hydrophobic sidechains in proximity allowing them to form tertiary interactions. In GCaMP6f, the cpEGFP - CaM helix I and helix IV-V linkers interact and stabilise one another. Thus the three mutations position the cpEGFP - CaM helix I linker with respect to RS-20 peptide - cpEGFP linker stabilising cpEGFP folding. In contrast, the T302, R303 and D380 residues, originally present in GCaMP3, allow the cpEGFP - CaM helix I linker to be more dynamic, thus increasing entropic penalty for cpEGFP folding in GCaMP3 with respect to GCaMP6f. In GCaMP3, the cpEGFP - CaM helix I linker and helix IV-V linkers are dynamic, reducing the stability of folded cpEGFP, explaining/causing its reduced brightness, which is the measure of the fraction of folded cpEGFP. The D395A mutation, introduced in GCaMP3fast and GCaMP6fu, prevents Ca2+ binding to the EF-3 site (flanked by helices V and VI), which thus, rather than being in an “open” conformation as in Ca2+-bound GCaMP-s (Fig. 5c), is expected to remain in “closed” conformation (Fig. 5d). Thus, the cpEGFP - CaM helix I linker is imperfectly poised with respect to RS-20 peptide - cpEGFP linker, cpEGFP folding is thus destabilised and the brightness is reduced in GCaMP3fast and GCaMP6fu. In GCaMP3, the CaM EF-hand 3 adopts “open” conformation, but the cpEGFP - CaM helix I linker remains dynamic, hence cpEGFP folding is still destabilised explaining its similar brightness to GCaMP3fast and GCaMP6fu. Closing the CaM EF-hand 3 conformation by the W43Y/D395A mutation thus has the equivalent effect on cpEGFP folding as destabilising the cpEGFP - CaM helix I linker.
We observed that GCaMP-type GECI have a limiting response rate that is independent of [Ca2+]25. Moreover, the Ca2+ rise kinetics of GCaMP6s and GCaMP6f revealed complex biphasic processes: although at 20 °C GCaMP6s and GCaMP6f have 20 ms and 2 ms response times, the amplitude of their fast phase diminishes with increasing temperature, thus presenting as slow indicators, at 37 °C. In contrast, GCaMP3fast and GCaMP6fu have greatly improved fluorescence rise time of 1 ms t1/2 at 37 °C. By targeting the CaM - RS20 peptide interface, GCaMP3 RS09 and GCaMP6f RS09 had improved decay t1/2-s of 25 and 20 ms (37 °C)23,24, compared to decay t1/2-s of GCaMP3 with 147 ms and GCaMP6f with 71 ms. However GCaMP3fast25 and GCaMP6fu have the fastest decay with a t1/2 of 3 ms, at 37 °C.
The fluorescence response kinetics of GCaMP-s have been modelled from the stopped-flow data. Previously a model has been put forward in which the Ca2+ response rate depends on the Ca2+ step: a small Ca2+ step results in slow binding to the C-lobe followed by fast binding to the low affinity the N-lobe; in contrast, a large step in Ca2+ evokes fast Ca2+ response via N-lobe binding and in this mode C-lobe binding is not required for the fluorescent state24. Our modeling studies reveal a different mechanism: first, that although N-lobe Ca2+ binding is necessary for Ca2+-induced fluorescence enhancement, it is not sufficient for the fluorescence response which also requires C-lobe Ca2+-binding; second, the limiting rate of the probes is determined by the Ca2+ association kinetics of the C-terminal CaM lobe in conjunction with the re-equilibration of the two postulated fluorescent states. Ca2+ binding is of lower affinity to the CaM N-lobe than to the C-lobe, however, in the presence of a target peptide the Ca2+ affinity of the N-lobe may be similar or higher than that of the C-lobe28. The Ca2+ binding kinetics of CaM-peptide complexes have not been determined, thus the rate constants for CaM were used29. Ca2+ dissociation from CaM and its peptide complexes is commonly thought to occur in pairs of Ca2+. Whether a single or double exponential process is observed for the fluorescence decay depends on the rates by which the putative two- and four-Ca2+ saturated states convert into each other and decay26.
Temperature dependencies of the Ca2+ rise kinetics suggest complex underlying activation thermodynamics. Positive, neutral and negative temperature-induced rate changes all occur, indicating that the EF-hand and peptide mutations have sensitively affected the balance of entropy and enthalpy gains. Favourable dehydration of hydrophobic surfaces results in entropy-driven activation and a positive temperature coefficient30. The lack of temperature dependence of the rates, e.g. GCaMP6f fast on-rate, is consistent with the limiting fast rate being Ca2+ binding, a diffusion limited process. Negative temperature coefficients observed for EF-3 and EF-3:4 mutants likely stem from less hydrophobic interaction and hence less positive entropy and more negative enthalpy change deriving from CaM C-lobe interaction with peptide in the absence of EF-3 or EF-4 Ca2+ binding and weakened binding of peptide due to W to Y substitution. Reduced brightness appears to be a trade-off for fast kinetics, presenting an opportunity for future improvements. While the EF-3 Ca2+ binding site is responsible for brightness, the EF-4 site is the guardian of cooperativity of the C-terminal CaM lobe for Ca2+ when binding the RS20 target peptide.
A commonly observed property of cpEGFP- and CaM-peptide interaction-based GECI is high cooperativity for Ca2+, often showing an all-or-none response to Ca2+ elevation as revealed by stopped-flow kinetic experiments on GCaMP3fast25 and GCaMP6fu. Fast all-or-none response to small changes in [Ca2+] would make GCaMP-type probes well suited for spike detection, however the current fast variants have insufficient brightness. RCaMP2 and some mGCaMP3, mG-GECO and mGEM-GECO have slower kinetics and reduced cooperativity for Ca2+ with Hill coefficients of 1–1.7 16,25, possibly by a combination of negatively and positively cooperative molecular responses, making them potentially useful for quantifying [Ca2+] changes in cells.
While the EF-3 single mutation raises the Kd to low μM, the EF-4 single and the EF-3:4 double mutations break up the affinity into two components, one with a Kd of low μM and one in the mM range with most of the fluorescence enhancement occurring in mM Ca2+. In the kinetic modeling only high affinity sites with μM Kd are considered. As there are only two Ca2+ binding sites in the EF-3:4 mutants, the low, mM affinity Ca2+ binding is likely attributable to the mutated EF-hand 3 (necessary for high brightness and dynamic range) which in the presence of the RS20 target peptide may acquire such affinity for Ca2+. EF-3:4 double EF-hand mutant probes with mM Kd-s may be for suitable for intra-organelle and extracellular applications, after further improvements to their brightness and dynamic range. mGCaMP6s EF-3:4 is the most promising low affinity probe with a 500 μM Kd and a 19-fold Ca2+-induced fluorescence enhancement (20 °C), comparing favourably with CEPIA14.
The success of monitoring intracellular Ca2+ dynamics requires that the detection range of the probe is appropriate for the size and time course of the [Ca2+] transient. In the conditions of ionomycin stimulation, the expected peak [Ca2+] was 0.4 to 0.8 μM31. GCaMP6s with Kd of 110 nM, 5–10-fold lower than the peak of the [Ca2+] transient, was thus expected to be mostly saturated and thus signal such a transient with close to its maximum dynamic range. However, at resting [Ca2+] of ~ 50–80 nM, there is already considerable Ca2+ binding to such a probe. As a result of the two parameters the measured ΔF/F0 of 18 for GCaMP6s in ionomycin stimulated HEK293T cells is a reasonable value.
Regarding the kinetics of Ca2+ indicators, it is evident that low Kd probes with slow response report slower intracellular Ca2+ dynamics than higher Kd probes with fast responses. GCaMP6fu and mGCaMP6f RS-1 EF-4 both showed 4-fold faster Ca2+ decay in response to ATP stimulation than GCaMP6f. By its two-fold faster response rate, in cardiac myocytes, GCaMP3fast revealed removal of Ca2+ and return to resting intracellular levels between each beat, a phenomenon not clearly resolved by GCaMP6f25.
It transpires that the brightness and dynamic range of GCaMP6fu are not sufficient for the detection of the post-synaptic dendritic [Ca2+] elevation evoked by a single AP. Although the kinetic properties of GCaMP6fu would allow the separation of individual AP-s even at 100 Hz, the actual Ca2+ transient reveals an integrated Ca2+ response, raising the possibility that the Ca2+ dynamics associated with AP firing limit the use of Ca2+ as an indicator of neuronal activity.
Although unable to detect single AP-s, GCaMP6fu with its fast rise and decay kinetics may still be useful for the detection of repeated AP-s with between-train intervals of tens rather than hundreds of milliseconds. The Ca2+ induced fluorescence rise times of GCaMP3 RS09 and GCaMP6f RS09 remained slow in physiological experiments23,24. In contrast, the Ca2+ rise rates following a train of 5 AP-s in organotypic hippocampal slices reported by the GCaMP6fu and mGCaMP6f RS-1 EF-4 probes were markedly faster than GCaMP6f. When comparing the novel variant GCaMP6fu to GCaMP3fast25, though they show similar kinetic properties, GCaMP6fu which has a 3-fold lower Kd (0.89 μM) compared to GCaMP3fast (2.8 μM) is more sensitive to small Ca2+ concentration changes and hence more suitable for Ca2+ imaging in neurons. Improved brightness and fluorescence dynamic range would help make GCaMP6fu with its ultrafast kinetics a useful physiological tool.
Materials and Methods
Materials
GCaMP6s and GCaMP6f plasmids were a gift from Douglas Kim (Addgene plasmid #40753 and #40755, respectively)19. pET41a and pEGFP-N1 vectors were obtained from Novagen and Clontech, respectively. XL10-Gold and BL21 (DE3) Gold cells were purchased from Invitrogen. Restriction enzymes were obtained from New England Biolabs and T4 DNA ligase from Fermentas.
Generation of improved GCaMP6 probes
The strategy previously developed and described for the improvement of GCaMP3 probes was followed to design, generate and purify mutants of GCaMP6s and GCaMP6f probes19. For protein expression, GCaMP6s and GCaMP6f were subcloned from pGP-CMV backbone into pET41a bacterial expression vector. Mutant GECI were generated by site-directed mutagenesis of CaM EF-hands and RS20 peptide as previously described25. GCaMP6s and GCaMP6f and their mutants were overexpressed as GST-fusion proteins overnight at 20 °C in the presence of 0.5 mM IPTG in E. Coli BL21(DE3) Gold cells. Cells were lysed by sonication and clarified lysates were purified by a single-step GST-chromatography (GSTrap, ÄKTA Purifier, GE Healthcare) in 50 mM Na+-HEPES pH 7.5, 200 mM NaCl and 10 mM glutathione, at 4 °C. Purity of the eluted fractions was determined by SDS-PAGE (6.4%–20% acrylamide/bisacrylamide gradient). Protein concentrations were measured spectroscopically at 280 nm by a Nanodrop 1000 spectrophotometer (Thermo Scientific) using an εo value of 76585 M−1cm−1 calculated from the amino acid composition for GCaMP6s, GCaMP6f and their EF-hand mutants and εo of 70710 M−1cm−1 for the RS-1 mutants32.
Quantum yield determination
Protein concentrations were adjusted such that the absorbance at the excitation wavelength (490 nm) was between 0.001 and 0.1. A series of dilutions was prepared in a buffered solution (50 mM HEPES-K+ pH 7.5, 100 mM KCl, 2 mM MgCl2 with either 5 mM EGTA or 1 mM CaCl2) and the fluorescence spectra were recorded on a Fluorolog3 spectrofluorimeter (Horiba Scientific) at 20 °C. The quantum yield measured for GCaMP6f in Ca2+-saturated buffer was used as a reference (Φ = 0.59)19. Data were plotted as integrated fluorescence intensity as a function of absorbance and fitted by linear regression. The gradient of the plots for the reference GCaMP6f and the protein to be measured are termed SGCaMP6f and Sprotein, respectively. Quantum yields were obtained using the following equation: Φprotein = ΦGCaMP6f × (Sprotein/SGCaMP6s).
pH sensitivity of GCaMP6s and GCaMP6f-derived proteins
To determine the apparent pKa for each protein in the presence and absence of Ca2+, a series of buffers with 0.5 pH unit intervals were prepared. Depending on their respective pH buffering range, appropriate buffer was used for the measurements (MES for pH 6–6.5, HEPES for pH 7–8, TRIS for pH 8.5–9 and CAPS for pH 10). The pH titrations were performed by recording fluorescence spectra of 1 μM protein in Ca2+-free (50 mM buffer, 100 mM KCl, 2 mM MgCl2, 2 mM BAPTA) or Ca2+-saturated (50 mM buffer, 100 mM KCl, 2 mM MgCl2,1 mM CaCl2) conditions (Fluorolog3, Horiba). BAPTA was chosen over EGTA as Ca2+ chelator because of its stable affinity for Ca2+ over the pH range33. All titrations were performed in triplicates and expressed as normalised mean ± s.e.m.
Determination of free Ca2+ concentrations ([Ca2+])
[Ca2+] were calculated using the Ca/Mg/ATP/EGTA Calculator v1 constants from Schoenmakers’ Chelator program for experiments at 20 °C and 37 °C34.
Equilibrium Ca2+ binding
Ca2+ affinity assays of GECI and mGECI were performed by continuous titration using an automated syringe pump (ALADDIN 1000, WPI) at 20 oC or 37 °C. GECI proteins at 50–100 nM concentration (50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2 and 5 mM EGTA) were titrated with 325 mM CaCl2 at a 10 μL/min flow rate in a stirred 3 mL cuvette. Fluorescence was measured at 492 nm excitation and 515 nm emission wavelengths on a Fluorolog3 spectrofluorimeter (Horiba Scientific). Fluorescence records were corrected for dilution and photobleaching. Data were normalised and expressed as bound fraction. Half-maximal brightness concentration (Kd) and cooperativity for Ca2+ (n) were obtained by fitting the data to the Hill equation using GraphPad Prism 6 software. All titrations were performed at least in triplicates and expressed as mean ± s.e.m.
Stopped-flow fluorimetry
Ca2+ association and dissociation kinetic experiments of GCaMP6s and GCaMP6f proteins were carried out on a Hi-Tech Scientific SF-61DX2 stopped-flow system at temperatures ranging from 15 °C to 37 °C. Fluorescence excitation was set to 492 nm and fluorescence emission was collected using a 530 nm cut-off filter. Experiments were performed at least in triplicates and three sets of data were averaged for analysis. Data were fitted to either a single or a double exponential to obtain the rise or decay rates using KinetAssyst software.
Association kinetics
The solution containing 1 μM protein in 50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2 and 10 mM EGTA was rapidly mixed (1:1) with 50 mM K+-HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2 and 10 mM EGTA containing increasing [Ca2+] concentrations (concentrations in the mixing chamber). For the determination of temperature dependence of Ca2+ association rates, protein samples at 1 μM concentration were mixed as above with saturating Ca2+ (7.5–20 μM final [Ca2+] in the mixing chamber).
Dissociation kinetics
The solution containing 1 μM protein in 50 mM K+-HEPES, 100 mM KCl, 2 mM MgCl2, pH 7.5 with saturating Ca2+ (0.5 mM) was rapidly mixed (1:1) with 50 mM K+-HEPES, 100 mM KCl, 2 mM MgCl2, 10 mM EGTA pH 7.5 (concentrations in the mixing chamber).
Cloning of mGECI into a mammalian expression vector
For expression in eukaryotic cells, the GCaMP6s and GCaMP6f mutant DNAs were subcloned from pET41a into pEGFP-N1 vectors by restriction-ligation using BglII and NotI restriction enzymes and T4 DNA ligase following manufacturer’s protocol. During this process, the egfp initially present in the pEGFP-N1 vector was replaced by the gcamp6 genes (without the GST tag).
Imaging of GCaMP6f variants in HEK293T cells
Cells were cultured in DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin at 37 °C and 5% CO2.
Ionomycin stimulation
Transfection of cells was carried out on 10 mm diameter coverslips with 0.6 μg DNA and 2.5 μL Lipofectamine 2000 in 100 μL OptiMem® for 1 h at 37 °C. Cells were imaged 16–24 h post-transfection in 10 mM HEPES pH 7.5, 145 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 10 mM glucose and 2 mM CaCl2. For determination of the fluorescence dynamic range, cells were imaged before and after stimulation by 10 μM ionomycin at 20 °C. Imaging was performed with a Leica SP1 confocal microscope using a HCX ApoL 40 × 0.8 NA water immersion objective, images were acquired at 512 × 512 pixel size. Experiments were performed at least in triplicates, elliptical regions of interest (ROI) were selected and data were analysed using Leica Application Suite.
ATP stimulation
HEK293T cells were transfected with GCaMP6f variants using Fugene HD following the manufacturer’s recommendations. Imaging was performed 16–24 h post-transfection at 37 °C (OKO lab incubation chamber) in a 35-mm glass bottom dish (MatTek) with a 3i Marianas spinning-disk confocal microscope equipped with a Zeiss AxioObserver Z1, a 40 × 1.3 NA oil immersion objective and a 3i Laserstack as excitation light source (488 nm). Emitted light was collected through a single bandpass filter (Yokogawa CSU-X filter wheel) onto a CMOS camera (Hamamatsu, ORCA Flash 4.0; 1152 × 1656 pixels). Cells were stimulated with 100 μM ATP and images were collected at 1 s intervals for 40 seconds. Elliptical ROI were stacked using ImageJ program. Data obtained from 14–24 cells was plotted and analysed on GraphPad Prism 6. Fluorescence decay times were determined from single exponential fits to the data.
Two-photon imaging of GCaMP6f, GCaMP6f u and mGCaMP6 RS-1 EF-4 in hippocampal slices
Sprague Dawley rats were purchased from Charles River. All experiments were conducted in accordance with the Canadian Council on Animal Care standards and guidelines, with approval of the Dalhousie University Committee on Laboratory Animals. Transverse organotypic hippocampal slices (350 μm) were made from brains of rat pups aged 6 to 8 postnatal days humanely killed by Schedule 1 procedure (anesthetic (ketamine) overdose followed by decapitation) and cultured on Millicell CM membranes for 5 to 6 days35,36. Hippocampal slices were transfected using biolistics as described previously37. Slice preparations were transferred to a recording chamber and superfused at 28 °C with artificial cerebrospinal fluid (containing 120 mM NaCl, 3 mM KCl, 2 mM MgSO4, 4 mM CaCl2, 1.2 mM NaH2PO4 and 11 mM glucose) saturated with a gas mixture of 95% O2/5% CO2.
An upright epifluorescence microscope (Olympus BX51WI) with a 60 × 1.0 NA IR water immersion objective (Olympus) and an MRC1024MP (Bio-Rad Microscience, Hemel Hampstead, United Kingdom) laser scanner with nondescanned photomultiplier tube detectors were used to view slices. Two-photon imaging was carried out 1–4 days post-transfection using a MaiTai titanium sapphire laser) at 930 nm.
Action potentials were evoked and recorded in expressing CA1 pyramidal neurons using a sharp intracellular electrode (60–80 MΩ) filled with 3 M KCl in 20 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid. Line scans taken at 2 ms interval across proximal apical dendrites were collected to determine the calcium transients measured as ΔF/F0 (defined as ΔF/F0 = 100 (Ftransient-Finitial)/(Finitial-Fbackground) corresponding to 5 AP-s evoked by brief depolarizing current injection at frequencies between 10–100 Hz via a Multiclamp 700B amplifier (Molecular Devices, California). Ca2+ decay kinetics of GCaMP6 variants were determined by monitoring fluorescence changes evoked by 5 APs at 100 Hz.
Electrophysiological and imaging data were collected and analysed with software from AxoGraph (AxoGraph Scientific, Sydney, Australia), LaserSharp (Bio-Rad Microscience) and ImageJ38.
Additional Information
How to cite this article: Helassa, N. et al. Design and mechanistic insight into ultrafast calcium indicators for monitoring intracellular calcium dynamics. Sci. Rep. 6, 38276; doi: 10.1038/srep38276 (2016).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Material
Acknowledgments
This work was funded by Wellcome Trust Project Grant 094385/Z/10/Z and BBSRC Project Grant BB/M02556X/1 to K.T., and by CIHR Grant MOP-123514 and NSERC Grant RGPIN-170421 to A.F. Dr. Silke Kerruth and Dr. Elizabeth R. Morris are thanked for comments on the manuscript. Use of the 3i-spinning confocal microscope at the Institute of Translational Medicine, Cellular and Molecular Physiology, University of Liverpool is acknowledged.
Footnotes
Author Contributions N.H. generated mutant proteins, carried out biophysical characterisation and data analysis, cell imaging, generated figures; B.P. and A.F. designed, performed and analysed experiments in hippocampal slices; K.T. designed and supervised the project, wrote the paper and carried out kinetic modelling.
References
- Fernandez-Alfonso T. et al. Monitoring synaptic and neuronal activity in 3D with synthetic and genetic indicators using a compact acousto-optic lens two-photon microscope. J. Neurosci. Methods. 222, 69–81 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akerboom J. et al. Crystal structures of the GCaMP calcium sensor reveal the mechanism of fluorescence signal change and aid rational design. J. Biol. Chem. 284, 6455–6464 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akerboom J. et al. Optimization of a GCaMP calcium indicator for neural activity imaging. J. Neurosci. 32, 13819–13840 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hendel T. et al. Fluorescence changes of genetic calcium indicators and OGB-1 correlated with neural activity and calcium in vivo and in vitro. J. Neurosci. 28, 7399–7411 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muto A. et al. Genetic visualization with an improved GCaMP calcium indicator reveals spatiotemporal activation of the spinal motor neurons in zebrafish. Proc. Natl. Acad. Sci. USA 108, 5425–5430 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakai J., Ohkura M. & Imoto K. A high signal-to-noise Ca2+ probe composed of a single green fluorescent protein. Nat. Biotechnol. 19, 137–141 (2001). [DOI] [PubMed] [Google Scholar]
- Ohkura M., Matsuzaki M., Kasai H., Imoto K. & Nakai J. Genetically encoded bright Ca2+ probe applicable for dynamic Ca2+ imaging of dendritic spines. Anal. Chem. 77, 5861–5869 (2005). [DOI] [PubMed] [Google Scholar]
- Souslova E. A. et al. Single fluorescent protein-based Ca2+ sensors with increased dynamic range. BMC. Biotechnol. 7, 37 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tallini Y. N. et al. Imaging cellular signals in the heart in vivo: Cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc. Natl. Acad. Sci. USA 103, 4753–4758 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tian L. et al. Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat. Methods. 6, 875–881 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- .Wang Q., Shui B., Kotlikoff M. I. & Sondermann H. Structural basis for calcium sensing by GCaMP2. Structure. 16, 1817–1827 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baird G. S., Zacharias D. A. & Tsien R. Y. Circular permutation and receptor insertion within green fluorescent proteins. Proc. Natl. Acad. Sci. USA 96, 11241–11246 (1999) [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao Y. et al. An expanded palette of genetically encoded Ca2+ indicators. Science. 333, 1888–1891 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Suzuki J. et al. Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA. Nat. Commun. 5, 4153 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henderson M. J. et al. A Low Affinity GCaMP3 Variant (GCaMPer) for Imaging the Endoplasmic Reticulum Calcium Store. PLoS One. 10, e0139273 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inoue M. et al. Rational design of a high-affinity, fast, red calcium indicator R-CaMP2. Nat. Methods. 12, 64–70 (2015). [DOI] [PubMed] [Google Scholar]
- Akerboom J. et al. Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front Mol. Neurosci. 6, 2 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berlin S. et al. Photoactivatable genetically encoded calcium indicators for targeted neuronal imaging. Nat. Methods. 12, 852–858 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen T. W. et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 499, 295–300 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muto A., Ohkura M., Abe G., Nakai J. & Kawakami K. Real-time visualization of neuronal activity during perception. Curr. Biol. 23, 307–311 (2013). [DOI] [PubMed] [Google Scholar]
- Ohkura M. et al. Genetically encoded green fluorescent Ca2+ indicators with improved detectability for neuronal Ca2+ signals. PLoS One. 7, e51286 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Podor B. et al. Comparison of genetically encoded calcium indicators for monitoring action potentials in mammalian brain by two-photon excitation fluorescence microscopy. Neurophotonics. 2, 021014 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Badura A., Sun X. R., Giovannucci A., Lynch L. A. & Wang S. S. Fast calcium sensor proteins for monitoring neural activity. Neurophotonics. 1, 025008 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun X. R. et al. Fast GCaMPs for improved tracking of neuronal activity. Nat. Commun. 4, 2170 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Helassa N. et al. Fast-Response Calmodulin-Based Fluorescent Indicators Reveal Rapid Intracellular Calcium Dynamics. Sci. Rep. 5, 15978 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Török K. & Trentham D. R. Mechanism of 2-chloro-(ε-amino-Lys75)-[6-[4-(N,N- diethylamino)phenyl]-1,3,5-triazin-4-yl]calmodulin interactions with smooth muscle myosin light chain kinase and derived peptides. Biochemistry. 33, 12807–12820 (1994). [DOI] [PubMed] [Google Scholar]
- Ding J., Luo A. F., Hu L., Wang D. & Shao F. Structural basis of the ultrasensitive calcium indicator GCaMP6. Sci. China Life Sci. 57, 269–274 (2014). [DOI] [PubMed] [Google Scholar]
- Persechini A., White H. D. & Gansz K. J. Different mechanisms for Ca2+ dissociation from complexes of calmodulin with nitric oxide synthase or myosin light chain kinase. J. Biol. Chem. 271, 62–67 (1996). [DOI] [PubMed] [Google Scholar]
- Faas G. C., Raghavachari S., Lisman J. E. & Mody I. Calmodulin as a direct detector of Ca2+ signals. Nat. Neurosci. 14, 301–304 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dunlap T. B., Kirk J. M., Pena E. A., Yoder M. S. & Creamer T. P. Thermodynamics of binding by calmodulin correlates with target peptide alpha-helical propensity. Proteins. 81, 607–612 (2013). [DOI] [PubMed] [Google Scholar]
- Schilling W. P., Sinkins W. G. & Estacion M. Maitotoxin activates a nonselective cation channel and a P2Z/P2X(7)-like cytolytic pore in human skin fibroblasts. Am. J. Physiol. 277, C755–C765 (1999). [DOI] [PubMed] [Google Scholar]
- Gill S. C. & von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319–326 (1989). [DOI] [PubMed] [Google Scholar]
- Tsien R. Y. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry. 19, 2396–2404 (1980). [DOI] [PubMed] [Google Scholar]
- Schoenmakers T. J., Visser G. J., Flik G. & Theuvenet A. P. CHELATOR: an improved method for computing metal ion concentrations in physiological solutions. Biotechniques. 12, 870–879 (1992). [PubMed] [Google Scholar]
- Emptage N., Bliss T. V. & Fine A. Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. Neuron. 22, 115–124 (1999). [DOI] [PubMed] [Google Scholar]
- Stoppini L., Buchs P. A. & Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37, 173–182 (1991). [DOI] [PubMed] [Google Scholar]
- McAllister A. K. Biolistic transfection of neurons. Sci. STKE. 2000, l1 (2000). [DOI] [PubMed] [Google Scholar]
- Schneider C. A., Rasband W. S. & Eliceiri K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9, 671–675 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.